February 21, 2025
The formulation of benzoyl peroxide (BP) products plays a role in the levels of benzene found, according to new research, with leave-on products found to have […]
February 20, 2025
Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to […]
February 19, 2025
TOPLINE: Mohs surgery was associated with improved outcomes compared with wide local excision (WLE) in patients with primary high-stage cutaneous squamous cell carcinoma (cSCC), showing lower […]
February 19, 2025
Why do we scratch? Scratching in response to itching is both pleasurable and harmful. In skin conditions, particularly dermatitis, scratching creates a vicious cycle, intensifying the […]
February 19, 2025
The European Commission has approved nemolizumab (Nemluvio) for subcutaneous use in treating moderate to severe atopic dermatitis (AD) in patients aged ≥ 12 years and moderate […]
February 18, 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for nemolizumab (Nemluvio, Galderma) to treat moderate to severe prurigo nodularis in adults and […]
February 14, 2025
The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA) has started a review of medicines containing finasteride and dutasteride following concerns about associated suicidal […]
February 13, 2025
TOPLINE: About 1 in 15 solid organ transplant patients per year develop actinic keratosis (AK), with men, White individuals, and lung transplant recipients at highest risk. […]
February 12, 2025
TOPLINE: Immune checkpoint inhibitors (ICIs) show promise for field cancerization, based on their ability to reduce actinic keratoses (AKs) in a new study. METHODOLOGY: This prospective […]